Table 2.
Cardiac Magnetic Resonance measures of subclinical CVD at baseline, by hs-cTnT category
| Subclinical CVD Measure | <LOD | 3.0–4.25 ng/L | 4.26–5.87ng/L | 5.88–8.80 ng/L | ≥8.81 ng/L | test for trend | |
|---|---|---|---|---|---|---|---|
| LVM (g) | Males | 130.5 (22.1) | 132.4 (24.4) | 135.9 (24.6) | 138.9 (25.4) | 148.3 (33.6) | <.001 |
| Females | 101.3 (18.3) | 103.5 (18.8) | 105.0 (20.2 | 108.2 (21.9) | 115.3 (28.1) | <.001 | |
| LVH Prevalence | Males | 13 (3.0%) | 23 (6.3%) | 30 (6.9%) | 32 (6.1%) | 110 (18.2%) | <.001 |
| Females | 85 (7.1%) | 51 (11.1%) | 49 (12.0%) | 47 (15.3%) | 64 (27.7%) | <.001 | |
| LVEDV (mL) | Males | 140.0 (26.2) | 142.1 (29.0) | 142.0 (29.9) | 143.0 (31.0) | 142.6 (35.9) | 0.2 |
| Females | 116.4 (22.3) | 117.9 (23.4) | 115.3 (23.3) | 117.1 (24.7) | 117.0 (27.8) | 0.9 | |
| LVEF (%) | Males | 61.0 (5.6) | 61.9 (5.9) | 61.5 (5.8) | 61.0 (6.2) | 60.4 (7.7) | .006 |
| Females | 63.5 (5.2) | 63.9 (6.0) | 63.8 (5.5) | 63.9 (6.0) | 63.0 (6.7) | 0.2 | |
| LVEF<50% | Males | 15 (3.4%) | 12 (3.3%) | 14 (3.2%) | 24 (4.5%) | 51 (8.4%) | <.001 |
| Females | 14 (1.2%) | 6 (1.3%) | 7 (1.7%) | 8 (2.6%) | 10 (4.3%) | <.001 |
Values are mean (standard deviation) and N (%).